Industry Insider: An Inside Look at ACell Inc.

For this month’s feature, Today’s Wound Clinic spoke with Arjun R. Ishwar, product manager. Today’s Wound Clinic (TWC): How long have you been in wound care, and how did you enter this area of healthcare? Arjun R. Ishwar (ARI): ACell has been in the wound care arena for nearly four years. I began my role as a clinical consultant within the dermal scaffolding field for major burns and trauma. TWC: What’s your day-to-day role? ARI: As product manager of a quickly growing regenerative medicine company, I identify clinical needs and work with a multidisciplinary team to develop and commercialize innovative products that help physicians and their patients. On a daily basis, my challenge is to merge marketing and clinical needs and increase sales. TWC: What do you find most rewarding about providing for your industry? ARI: We have been rewarded with the ability to touch a great number of lives. It is our goal to continue to impact the medical field with a technology that is unprecedented. TWC: How would you describe the overall mission of your company? ARI: ACell is committed to providing high-quality products that positively change patient care. TWC: What’s new with your company in 2013? ARI: ACell is on the leading edge of medical device technology. In 2013, ACell is planning to introduce products for new indications that will immediately impact patient care. TWC: How is your company unique? ARI: ACell offers a proprietary technology in the form of unique extracellular matrix products that repair and remodel damaged tissues. ACell’s flagship product, MatriStem,® has applications ranging from abdominal wall reconstruction to chronic wound closure. TWC: Why are you passionate about the work of your company? ARI: The most touching moment of my professional career was observing a patient survive a “code” in the operating room. After resuscitation, ACell was used to help the patient. Today, the patient lives a healthy and fulfilling life. Our product changes lives. TWC: How is your company approaching challenges in wound care? ARI: MatriStem devices have been used successfully, often in situations when all else has failed. While certain hurdles exist in the ever-changing healthcare market, ACell is proactively researching and conducting clinical trials that demonstrate superiority. TWC: What are your most popular products and/or services? ARI: MatriStem MicroMatrix® is a product completely unique to the market. For this reason, physicians around the country have adopted this product into modern practice for a multitude of advanced wound care procedures. TWC: How do you ensure proper training on products and services? ARI: ACell is committed to the education of its personnel and for the medical professionals we serve. The company has increased our commitment toward professional education significantly and hosts training events frequently. TWC: What are the future goals for you and your company? ARI: The future for ACell holds enormous promise. ACell will be the recognized leader in regenerative extracellular matrix technology, offering superior healing options for doctors and patients. We are dedicated to creating high-quality, innovative solutions that we believe will transform standards of medical care, improving the quality of life of patients. ACell is committed to becoming and remaining an innovative leader in regenerative medical technology.